$24.76
0.160.65%
À la fermeture: -
$24.76
-0.000200.00%
Après les heures de négociation: Aug 29, 7:59 PM EDT
Comments
Loading...
Orientation et prévision
Pfizer publie des prévisions sur le BPA et les revenus futurs, donnant aux investisseurs un aperçu du montant que la société s'attend à gagner au cours des prochaines périodes.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
08/05/2025 | PFE | Pfizer | FY | 2025 | $2.90 | $3.10 | $3.03 | $61.00B | $64.00B | $62.90B | |
04/29/2025 | PFE | Pfizer | FY | 2025 | $2.80 | $3.00 | $2.95 | $61.00B | $64.00B | $62.92B | |
02/04/2025 | PFE | Pfizer | FY | 2025 | $2.80 | $3.00 | $2.93 | $61.00B | $64.00B | $63.00B | |
12/17/2024 | PFE | Pfizer | FY | 2025 | $2.80 | $3.00 | $2.88 | $61.00B | $64.00B | $63.28B | |
12/17/2024 | PFE | Pfizer | FY | 2024 | $2.75 | $2.95 | $2.93 | $61.00B | $64.00B | $62.88B | |
10/29/2024 | PFE | Pfizer | FY | 2024 | $2.75 | $2.95 | $2.65 | $61.00B | $64.00B | $61.16B | |
07/30/2024 | PFE | Pfizer | FY | 2024 | $2.45 | $2.65 | $2.38 | $59.50B | $62.50B | $60.70B | |
05/01/2024 | PFE | Pfizer | FY | 2024 | $2.15 | $2.35 | $2.21 | $58.50B | $61.50B | $60.02B | |
01/30/2024 | PFE | Pfizer | FY | 2024 | $2.05 | $2.25 | $2.26 | $58.50B | $61.50B | $60.47B | |
12/13/2023 | PFE | Pfizer | FY | 2023 | $1.45 | $1.65 | $1.56 | $58.00B | $61.00B | $58.81B | |
12/13/2023 | PFE | Pfizer | FY | 2024 | $2.05 | $2.25 | $3.16 | $58.50B | $61.50B | $63.07B | |
10/31/2023 | PFE | Pfizer | FY | 2023 | $1.45 | $1.65 | $1.65 | $58.00B | $61.00B | $55.37B | |
10/13/2023 | PFE | Pfizer | FY | 2023 | $1.45 | $1.65 | $3.30 | $58.00B | $61.00B | $66.02B | |
08/01/2023 | PFE | Pfizer | FY | 2023 | $3.25 | $3.45 | $3.01 | $67.00B | $70.00B | $61.01B | |
05/02/2023 | PFE | Pfizer | FY | 2023 | $3.25 | $3.45 | $3.36 | $67.00B | $71.00B | $68.67B | |
01/31/2023 | PFE | Pfizer | FY | 2023 | $3.25 | $3.45 | $4.44 | $67.00B | $71.00B | $74.13B | |
11/01/2022 | PFE | Pfizer | FY | 2022 | $6.40 | $6.50 | $6.38 | $99.50B | $102.00B | $99.60B | |
07/28/2022 | PFE | Pfizer | FY | 2022 | $6.30 | $6.45 | $6.62 | $98.00B | $102.00B | $102.92B | |
05/03/2022 | PFE | Pfizer | FY | 2022 | $6.25 | $6.45 | $7.15 | $98.00B | $102.00B | $107.94B | |
02/08/2022 | PFE | Pfizer | FY | 2022 | $6.35 | $6.55 | — | $98.00B | $102.00B | — | |
11/02/2021 | PFE | Pfizer | FY | 2021 | $4.13 | $4.18 | — | $81.00B | $82.00B | — | |
07/28/2021 | PFE | Pfizer | FY | 2021 | $3.95 | $4.05 | $3.70 | $78.00B | $80.00B | $72.78B | |
05/04/2021 | PFE | Pfizer | FY | 2021 | $3.55 | $3.65 | $3.36 | $70.50B | $72.50B | $62.99B | |
02/02/2021 | PFE | Pfizer | FY | 2021 | $3.10 | $3.20 | $3.19 | $59.40B | $61.40B | $56.72B | |
01/12/2021 | PFE | Pfizer | FY | 2021 | $3.00 | $3.10 | $3.07 | — | — | — |
FAQ
Quelles sont les dernières directives pour Pfizer (PFE) ?
Les dernières prévisions pour Pfizer (PFE) ont été communiquées le août 5, 2025 pour l'année complète 2025. L'entreprise a fourni des prévisions de bénéfice par action dans une fourchette de $2.90 à $3.10, par rapport à un BPA estimé de $3.03. De plus, Pfizer a prévu un chiffre d'affaires entre $61.00B et $64.00B pour le trimestre.
Parcourir guidance et prévisions sur toutes les actions.